Methods for treating juvenile arthritis with anti-bile salt-stimulated lipase (bssl) antibodies
AssigneeLipum AB
InventorsOLLE HERNELL, SUSANNE LINDQUIST, LENNART GUSTAV LUNDBERG
Life of this patent
Estimating the term…
Abstract
It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
Claims18
A method for reduction of incidence and/or severity, prophylaxis and/or treatment of an inflammatory disease comprising administering a pharmaceutical effective amount of a BSSL antagonist to a subject in need of such treatment.
A pharmaceutical composition comprising a BSSL antagonist and a pharmaceutically acceptable carrier or excipient for use in reduction of incidence and/or severity, prophylaxis and/or treatment of an inflammatory disease.
A method of manufacturing a pharmaceutical composition for reduction of incidence and/or severity, prophylaxis and/or treatment of an inflammatory disease, comprising:
- mixing a BSSL antagonist with a pharmaceutically acceptable carrier or excipient.
Dependencies are inferred from the claim text.